Lee Jung Hwan, Nandy Sandip K, Lawrence David S
The Albert Einstein College of Medicine, Department of Biochemistry, 1300 Morris Park Ave., Bronx, New York 10461, USA.
J Am Chem Soc. 2004 Mar 24;126(11):3394-5. doi: 10.1021/ja037300b.
A potent and highly selective inhibitor of protein kinase C alpha has been generated via the combinatorial modification of a consensus sequence peptide. The inhibitor displays a Ki of 800 pM versus variable peptide substrate and good selectivity versus other members of the PKC family, including PKCbeta (385-fold), PKCgamma (580-fold), PKCdelta (2730-fold), PKCepsilon (600-fold), PKCeta (1310-fold), PKCtheta (1210-fold), PKCiota (940-fold), and PKCzeta (640-fold). The parallel synthesis strategy employed is easily automated and straightforward to implement.
通过对共有序列肽进行组合修饰,生成了一种强效且高度选择性的蛋白激酶Cα抑制剂。该抑制剂对可变肽底物的抑制常数(Ki)为800皮摩尔,对蛋白激酶C(PKC)家族的其他成员具有良好的选择性,包括PKCβ(385倍)、PKCγ(580倍)、PKCδ(2730倍)、PKCε(600倍)、PKCη(1310倍)、PKCθ(1210倍)、PKCι(940倍)和PKCζ(640倍)。所采用的平行合成策略易于自动化且实施简单。